Efficacy and safety evaluation of sucrose-formulated recombinant factor VIII for Taiwanese patients with haemophilia A

被引：10

作者：

Young, J. -H. ^{[1
]}

Liu, H. -C. ^{[2
]}

Hsueh, E. -J. ^{[3
]}

Huang, M. -L. ^{[4
]}

Peng, C. -T. ^{[5
]}

Chen, R. -L. ^{[6
]}

Maas-Enriquez, M. ^{[7
]}

Achilles, K. ^{[8
]}

机构：

[1] Lin Shin Hosp, Taichung, Taiwan

[2] Mackay Mem Hosp, Taipei, Taiwan

[3] Pingtung Christian Hosp, Pingtung, Taiwan

[4] Show Chwan Mem Hosp, Changhua, Taiwan

[5] China Med Coll Hosp, Taichung, Taiwan

[6] Chi Mei Fdn Med Ctr, Tainan, Taiwan

[7] Bayer HealthCare, Wuppertal, Germany

[8] Bayer Vital GmbH, Leverkusen, Germany

来源：

HAEMOPHILIA | 2009年 / 15卷 / 04期

关键词：

D O I：

10.1111/j.1365-2516.2009.02024.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：968 / 970

页数：3

共 5 条

[1]

Abshire TC, 2000, THROMB HAEMOSTASIS, V83, P811

[2] An observational study of sucrose-formulated recombinant factor VIII for Japanese patients with haemophilia A [J].

Delumeau, Jean-Christophe ;

Ikegawa, Chiho ;

Yokoyama, Chisato ;

Haupt, Verena .

THROMBOSIS AND HAEMOSTASIS, 2008, 100 (01) :32-37

[3] The epidemiology of factor VIII inhibitors [J].

Hay, Charles R. M. .

HAEMOPHILIA, 2006, 12 :23-28

[4] Safety and efficacy of sucrose-formulated full-length recombinant factorVIII: Experience in the standard clinical setting [J].

Musso, Roberto ;

Santagostino, Elena ;

Faradji, Albert ;

Iorio, Alfonso ;

van der Meer, Jan ;

Ingerslev, Jorgen ;

Lambert, Thierry ;

Maas-Enriquez, Monika ;

Gorina, Eduard .

THROMBOSIS AND HAEMOSTASIS, 2008, 99 (01) :52-58

[5] Safety and efficacy of a sucrose-formulated recombinant factor VIII product for the treatment of previously treated patients with haemophilia A in China [J].

Shi, J. ;

Zhao, Y. ;

Wu, J. ;

Sun, J. ;

Wang, L. ;

Yang, R. .

HAEMOPHILIA, 2007, 13 (04) :351-356

← 1 →